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Human migration is at an all-time high, with one in every
122 humans now either a refugee, internally displaced, or
seeking asylum (unhcr.org/news/latest/2015/6/558193896/
worldwide-displacement-hits-all-time-high-war-persecution-
increase.html). This global humanitarian crisis has spurred
vigorous local, national, and international debates regarding
the risk of infectious diseases that migrants pose to the
countries and citizens who offer them shelter. In these
debates, some have advocated tightened control and over-
sight of immigration, acceptance of refugees, and international
travel. In this context, it is essential to maintain established
U.S. policy toward human migration and global health that
is evidence based and upholds the value of compassion,
as well as key principles in international human rights law.
Although travel restrictions may be warranted under extreme
circumstances of epidemics and pandemics, as spelled out
by the World Health Organization International Health Regu-
lations (who.int/topics/international_health_regulations/en/),
experience informs us that limiting migration and the flow
of refugees will, by itself, have little impact on the control of
infectious diseases. Migrants represent only a small fraction
of international travelers entering the United States. Thus,
preventing their entry will not have a major impact on the
influx of infections. International travel, once considered
exotic, is now commonplace. Over 70 million U.S. citizens
travel abroad yearly for commerce, trade, tourism, teaching,
faith-based missions and other public service efforts, and mili-
tary deployment. In contrast, about 1 million legal immigrants
and 70,000–90,000 refugees enter the United States yearly.
Unlike U.S. citizens, who travel freely without health screen-
ings or restrictions, legal migrants and refugees who enter
the country must meet entry criteria that include thorough
screening and treatment of infectious diseases. American
travelers returning to the United States have proven to be
highly efficient in spreading some infectious diseases. For
example, of the almost 4,500 recognized cases of Zika virus
infection to date in the United States, over 95% were travel
related (cdc.gov/zika/geo/united-states.html). Furthermore,
some “tropical” infections we may fear from migrants are
already endemic, albeit uncommon, in parts of the United
States, including viral infections, tuberculosis, Chagas dis-
ease, leishmaniasis, and soil-transmitted helminth infections.
Restrictions on travel and population movement cannot keep
these diseases out of our country. They are already here.
In addition to maintaining a humane and evidence-based
U.S. policy on migration, we must continue to engage and
invest in programs that improve the health of vulnerable
populations worldwide. Reaching out to enhance the well-
being of those whose lives has been torn apart by war and
oppression should be a fundamental and perhaps defining
American principle. Programs for populations in need around
the world should not be considered antiquated historical
notions or reflective of an outmoded inscription on the Statue of
Liberty. Indeed, U.S. government leaders from both sides of
the political aisle have championed programs aimed at global
health, including the creation of the Peace Corps by Presi-
dent John F. Kennedy in 1961, and the President’s Emer-
gency Plan for AIDS Relief and President’s Malaria Initiative by
President George W. Bush in 2003 and 2005, respectively.
Additional efforts have been shared with other developed
countries, notably the Global Fund to Fight AIDS, Tuberculosis,
and Malaria. These well-managed programs have offered enor-
mous benefits to the citizens of the developing world, but they
have also directly benefitted the United States, by helping to
control some of the most important infectious diseases that
threaten all of us, by building diplomatic bridges of good will
with populations around the world, and by exemplifying the
best of American values of kindness and compassion.
Progress in diagnosing, managing, and preventing trop-
ical infectious diseases will be facilitated by biomedical
research in the developing world, where greater preva-
lence of many infections allows adequate sample size
for studies that would not be possible through research
conducted only in the United States. New drugs, vaccines,
and control measures that result from these research efforts
will be available for the benefit of all, including those in the
United States. Maintaining this research will require contin-
ued funding for U.S.-based agencies and programs that
support global health research and service, including the
National Institutes of Health, Centers for Disease Control
and Prevention, U.S. Agency for International Development,
and many Department of Defense programs.
The American Society of Tropical Medicine and Hygiene,
the largest international organization of experts dedicated to
reducing the worldwide burden of tropical infectious disease
and improving global health, deeply understands that vigilance
in the control of global disease is in the best interest of
all. To that end, we will continue to work with the U.S.
Congress, the White House, and global health stakeholders
in support of evidence-based policies and programs to
protect the health of people both inside and outside the
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United States. Maintenance of evidence-based policies
concerning migration and strong investment in global infec-
tious disease research and programs are the right thing to do,
and they are the smart thing to do.
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